Stivarga 40 MG tablet 21S
Ended Awarded
- Contract number
- SPE2DR26FFBK1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,429
Award facts
- Contract value 100% obligated
- $31,429.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,429.26 to DMS Pharmaceutical Group Inc. for Stivarga 40 mg tablets on November 7, 2025, with completion scheduled for November 10, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation under a firm fixed-price contract structure. This delivery order represents one of numerous purchases issued to the vendor by DLA's Medical Supply Chain division to support federal pharmaceutical supply requirements.
This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare operations globally. Under the $499,999,999 IDC ceiling awarded on November 13, 2025, and extending through December 31, 2036, DMS Pharmaceutical Group serves as one of multiple regional prime vendor contractors authorized to supply branded and generic prescription medications, biologics, vaccines, and medical consumables to military healthcare facilities worldwide, enabling efficient delivery of specialized pharmaceutical products across the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FFBK1?
SPE2DR26FFBK1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26FFBK1 worth?
The government has obligated $31,429 on SPE2DR26FFBK1.
Is contract SPE2DR26FFBK1 an order under another contract?
Yes. SPE2DR26FFBK1 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBK1 competed?
The extent of competition for SPE2DR26FFBK1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award